By combining CD47-SIRPα disruption with IgA antibodies against HER2, one group was able to enhance tumor cell opsonization and decrease tumor burden via neutrophil trogocytosis, a method of acquiring target cell plasma membrane fragments[10]. Here, ERBB2 is linked to neoplasm.